Dermaliq Therapeutics locks in $15m Series A

Dermaliq Therapeutics Inc, a new Delaware-based pharmaceutical development company, has raised $15 million in Series A financing.

Dermaliq Therapeutics Inc, a new Delaware-based pharmaceutical development company, has raised $15 million in Series A financing. The lead backer was 3E Bioventures Capital.

Source: Press Release